The line on every active MYKO label reads "Active Botanical — 100 mg." Here's what that means, why we name it that way, and how the framework changes the way the rest of the formula is used.
Open any active MYKO bottle — NEUROGENESIS, CORTEX, EMBODY, or EUPHORIA — and the first line on the supplement facts panel reads Active Botanical — 100 mg.
If you've spent any time in the cognitive supplement category, you'll notice that phrasing is unusual. Other brands name their hero compound by species. MYKO names a role. The reason matters — for the formula architecture, for the way the brand sits with regulators, and most importantly for how the product is meant to be used.
This piece is the explainer. What "Active Botanical" is functionally, why we hold the framing generic, and what microdosing context the framework lives inside.
What the term is doing
"Active Botanical" is a functional label, not a species name. It points at a class of compound that operates at the signal layer of the formula — the input designed to support pathways associated with cognitive flexibility and neuroplasticity, at a sub-perceptual 100 mg dose.
We refer to it as the Active Botanical for compliance reasons. Specifics are detailed in the documentation included with your product. The naming convention is a deliberate compliance posture, not vagueness for the sake of vagueness — the brand is positioning itself carefully around a category that is regulated differently in different jurisdictions.
That's the disclosure. The interesting part is what the framework changes about how the bottle is used.
Why protocol-style use, not daily indefinite use
The presence of an Active Botanical in a formula is the single biggest reason the formula is designed for protocol-style use over a 4–8 week arc rather than daily indefinite use.
This is the cleanest way to think about it: the Active Botanical formulas (NEUROGENESIS, CORTEX, EMBODY, EUPHORIA) are protocol formulas. ADAPT, the only MYKO formula without an Active Botanical, is the daily-foundation formula and is built for indefinite use.
The protocol framing matters because it changes the unit of analysis. Most cognitive supplements are evaluated by the day — did I feel something today? The Active Botanical formulas are evaluated by the arc. Did this 6-week protocol change my baseline in a way that's visible looking back over the period?
People who run the protocols correctly tend to find them effective. People who treat them like daily multivitamins tend to find them confusing.
The two protocol rhythms most people use
For users new to microdosing protocol literature, two rhythms dominate the practitioner conversation:
The Stamets protocol — 4 ON / 3 OFF. Take the formula for four consecutive days, then take three days off. Repeat that cycle for 4–8 weeks. Most users take the formula in the morning on the ON days.
The Fadiman protocol — 1 ON / 2 OFF. Take the formula on day one, then take days two and three off. Repeat for 4–8 weeks. The off days are a deliberate structural feature, not a permission to skip; the receptor systems the Active Botanical engages benefit from the spacing.
Neither protocol is "better" than the other. They serve slightly different practitioner profiles and tolerances. The MYKO product pages have protocol-cadence guidance in the protocol section; the underlying lesson is that the formula is used in a rhythm, not every day forever.
Why 100 mg and what "sub-perceptual" means
The 100 mg dose is deliberate.
The Active Botanical class can be used at a range of doses, but the dose that sits inside MYKO formulas is in the sub-perceptual range — meaning it is not designed to produce a noticeable acute experience the way a higher dose would. Users on a MYKO protocol typically do not report a felt "trip" or strong subjective shift on dose days. What they report is a slow change over the course of an arc — better cognitive flexibility, easier integration, a baseline that feels different at week six than it did at week one.
This is the entire point of the microdose framing. A higher dose of the same compound class would produce a different felt experience and a different use case (one that has its own legitimate practitioner literature, and that is well outside what MYKO's formulas are designed for or pointing at). The 100 mg dose is the cognitive-pathway-support dose.
If you are looking for a strong acute experience from a single capsule, MYKO will disappoint you. The formula is engineered for the slow arc.
Why we hold the species name off the front label
Three reasons.
One: compliance discipline. The compound class is regulated differently in different jurisdictions. Holding the framing at "Active Botanical" rather than naming a specific species lets the brand operate in jurisdictions where the operations team has verified availability and use is permitted.
Two: the species varies. Most MYKO active formulas use a standard Active Botanical variant. EUPHORIA, the premium tier, uses a different rare-species variant chosen for a warmer signature. The unified front-label framing across the line lets the product family share a clean visual identity while the formulation specifics live in the documentation that ships with the product.
Three: customer self-selection. The customer who reads the label carefully and understands the Active Botanical positioning is the customer who reads the documentation and uses the formula on protocol cadence. The customer who needs the species name on the front to make a purchase decision is usually not the customer the protocol formulas were built for.
How the Active Botanical interacts with the rest of the formula
The Active Botanical isn't the whole formula. It's the signal layer in a four-role architecture — signal, growth, fuel, delivery — that the rest of the bottle is built around.
In NEUROGENESIS, the Active Botanical is paired with Lion's Mane (growth, NGF-related support), Cordyceps (fuel, energy metabolism), and Shilajit (delivery, mineral foundation). In CORTEX, the Active Botanical is paired with Cordyceps (fuel, steady energy under load), Reishi (growth-equivalent, calm-supportive backbone), and Shilajit. The pattern repeats across the active formulas with the supporting mushrooms chosen for the pathway.
This matters because the Active Botanical is not a hero compound asking the rest of the formula to support it. It is one role inside a complete circuit, and its effects on a protocol arc are inseparable from what the supporting mushrooms and minerals are doing alongside it.
The longer version of the architecture is in The Four-Role Architecture: How MYKO Formulas Are Built.
Safety
The safety information on the back label is specifically calibrated to the Active Botanical's pharmacology. The headline cautions:
— Do not combine active formulas with lithium.
— Consult a healthcare professional before use if taking SSRIs, SNRIs, MAOIs, psychiatric medications, or if you have a personal or family history of psychosis or Bipolar I.
— Not for pregnancy, nursing, or anyone under 18.
These cautions appear on every active MYKO formula because they apply to every formula that contains an Active Botanical. ADAPT (no Active Botanical) carries a smaller daily-foundation safety block.
If any of the above criteria apply to you, the back label is asking you to talk to a clinician you trust before taking the formula. The Library exists to teach, not to substitute for that conversation.
A practical mental model
If you take one thing from this piece, take this:
The Active Botanical is what makes a MYKO formula a protocol formula. It's why the active line is used in 4–8 week arcs instead of forever. It's why ADAPT (no Active Botanical) is the only formula designed for indefinite daily use. It's why the felt experience is slow, structural, and looking-back-at-the-arc rather than acute and looking-at-today.
The framing makes the product architecture coherent. ADAPT is your daily foundation. The active formulas are your protocol vehicles. The companion stack finishes the practice. The Active Botanical is the input that makes that division meaningful.
If you understood that, you understand the brand.